Finance
Markets
No recent trading data. The last price we hold for COR is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

COR

stock Healthcare Medical Distribution
Cencora
$263.64 -1.20 (-0.45%) Delayed · quoted 46d ago
Mixed 41% Steady

What the indicators say

Bearish 0 of 5 trend signals bullish
Momentum · RSI 14 Leaning bearish
37
0oversold 30overbought 70100

RSI 37 — soft momentum, not yet oversold.

EMA 21 $272.28
Below
Near-term trend is down
SMA 50 $295.00
Below
Medium-term trend is down
SMA 200 $325.71
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $285.13
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $261.35 High $266.26
Open
$263.61
-0.46%
Close
$263.61
-0.46%
52-week range where the price sits across its year
52w low $244.82 52w high $377.54
Current
$263.61
Prev close
$264.84
Volume 0.69× the 3-month average
0 avg 2× avg
Today
1.21M
3-mo avg
1.74M

Earningscalendar synced from Yahoo 57d ago

Most recent
May 676 days ago
Next expected
Aug 5in 15 days

Recent earnings dates

  • May 6 76 days ago
  • Feb 4 167 days ago
  • Nov 5, 2025 258 days ago
  • Aug 6, 2025 349 days ago

Past earnings dates come from COR’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), COR’s fundamentals read as fair overall.

P/E ratio Strong
20.2x

At 20.2x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.83%

A 0.8% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Weak
0.5%

A 0.5% margin is thin; little of each revenue dollar survives as profit.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
103.1%

A 103.1% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
2.0%

A 2.0% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Weak
0.90

At 0.90, short-term assets fall short of short-term bills; liquidity is tight.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+9.3%

Revenue grew 9.3% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Fair
+3.0%

Net income grew 3.0% from the prior year: steady profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $214.0B$238.6B$262.2B$294.0B$321.3B
Net income $1.5B$1.7B$1.7B$1.5B$1.6B
Diluted EPS $7.39$8.04$8.53$7.53$7.96
Dividend / share $1.76$1.84$1.94$2.04$2.20
Total assets $57.3B$56.6B$62.6B$67.1B$76.6B
Total liabilities
Shareholder equity $584.4M$71.3M$666.3M$645.9M$1.5B

Leadershipsynced from SEC 57d ago

  • Mauch Robert P. President & CEO · Director
  • Cleary James F Chief Financial Officer
  • Battaglia Silvana Executive Vice President
  • Campbell Elizabeth S Executive Vice President
  • Krikorian Lazarus SVP & Chief Accounting Officer
  • Baumann Werner Director
  • Clyburn Frank Director
  • Cooper Ellen Director
  • Durcan Dermot Mark Director
  • Greenberg Lon R Director
  • Kim Lorence H. Director
  • Miller Redonda Director
  • Nally Dennis M Director
  • Ryerkerk Lori Director
  • Tyler Lauren M Director

Officers and board are drawn from COR’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$2.25
2026 so far
$1.202 payments
2026 projected
$2.40+6.7% vs 2025

Projection scales COR’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • May 15 $0.60
  • Feb 13 $0.60
  • Nov 14, 2025 $0.60
  • Aug 15, 2025 $0.55
  • May 16, 2025 $0.55
  • Feb 14, 2025 $0.55
  • Nov 15, 2024 $0.55
  • Aug 9, 2024 $0.51
  • May 9, 2024 $0.51
  • Feb 8, 2024 $0.51
  • Nov 10, 2023 $0.51
  • Aug 10, 2023 $0.48
  • May 11, 2023 $0.48
  • Feb 9, 2023 $0.48
  • Nov 10, 2022 $0.48
  • Aug 12, 2022 $0.46
  • May 13, 2022 $0.46
  • Feb 11, 2022 $0.46
  • Dec 1, 2021 $1.27
  • Nov 12, 2021 $0.46
  • Sep 29, 2021 $1.27
  • Aug 13, 2021 $0.44
  • Jun 29, 2021 $1.27

Recent SEC filingssynced from SEC 51d ago